載入...
Outcome measures for clinical trials assessing treatment of cystic fibrosis lung disease
Cystic fibrosis (CF) is a complex genetic disease characterized by death from loss of lung function. Therapies target pathophysiologic changes associated with pulmonary disease progression. Although therapeutic mechanisms differ, efficacy demonstration is limited to a few accepted outcome measures,...
Na minha lista:
| 發表在: | Clin Investig (Lond) |
|---|---|
| Main Authors: | , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2012
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4486293/ https://ncbi.nlm.nih.gov/pubmed/26146539 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4155/cli.11.174 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|